Incidence, Risk Factors and Evaluation of Osteoporosis in Patients With Inflammatory Bowel Disease: A Danish Population-Based Inception Cohort With 10 Years of Follow-Up

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Incidence, Risk Factors and Evaluation of Osteoporosis in Patients With Inflammatory Bowel Disease : A Danish Population-Based Inception Cohort With 10 Years of Follow-Up. / Lo, Bobby; Holm, Jakob Præst; Vester-Andersen, Marianne Kajbæk; Bendtsen, Flemming; Vind, Ida; Burisch, Johan.

In: Journal of Crohn's & colitis, Vol. 14, No. 7, 2020, p. 904-914.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Lo, B, Holm, JP, Vester-Andersen, MK, Bendtsen, F, Vind, I & Burisch, J 2020, 'Incidence, Risk Factors and Evaluation of Osteoporosis in Patients With Inflammatory Bowel Disease: A Danish Population-Based Inception Cohort With 10 Years of Follow-Up', Journal of Crohn's & colitis, vol. 14, no. 7, pp. 904-914. https://doi.org/10.1093/ecco-jcc/jjaa019

APA

Lo, B., Holm, J. P., Vester-Andersen, M. K., Bendtsen, F., Vind, I., & Burisch, J. (2020). Incidence, Risk Factors and Evaluation of Osteoporosis in Patients With Inflammatory Bowel Disease: A Danish Population-Based Inception Cohort With 10 Years of Follow-Up. Journal of Crohn's & colitis, 14(7), 904-914. https://doi.org/10.1093/ecco-jcc/jjaa019

Vancouver

Lo B, Holm JP, Vester-Andersen MK, Bendtsen F, Vind I, Burisch J. Incidence, Risk Factors and Evaluation of Osteoporosis in Patients With Inflammatory Bowel Disease: A Danish Population-Based Inception Cohort With 10 Years of Follow-Up. Journal of Crohn's & colitis. 2020;14(7):904-914. https://doi.org/10.1093/ecco-jcc/jjaa019

Author

Lo, Bobby ; Holm, Jakob Præst ; Vester-Andersen, Marianne Kajbæk ; Bendtsen, Flemming ; Vind, Ida ; Burisch, Johan. / Incidence, Risk Factors and Evaluation of Osteoporosis in Patients With Inflammatory Bowel Disease : A Danish Population-Based Inception Cohort With 10 Years of Follow-Up. In: Journal of Crohn's & colitis. 2020 ; Vol. 14, No. 7. pp. 904-914.

Bibtex

@article{fc6883c8fe754d7291c2f080b3953445,
title = "Incidence, Risk Factors and Evaluation of Osteoporosis in Patients With Inflammatory Bowel Disease: A Danish Population-Based Inception Cohort With 10 Years of Follow-Up",
abstract = "BACKGROUND: Patients with inflammatory bowel disease [IBD] including Crohn's disease [CD] and ulcerative colitis [UC] are at risk of developing metabolic bone disease. The aims here were to investigate the screening strategy, incidence and risk factors of osteoporosis in a prospective population-based inception cohort. METHOD: Between 2003 and 2004 all incident patients diagnosed with CD and UC in a well-defined Copenhagen area were included and followed until 2015. Data were compared with a control population [at a ratio of 1:20]. Regression models were performed with several covariates. The sensitivity of the Danish registries for osteoporosis was also assessed. RESULTS: A total of 513 patients were included [213 CD, 300 UC]. Overall, 338 (66%, CD: 164 [77%], UC: 174 [58%], p < 0.001] patients received ≥ 500 mg corticosteroid within a year, resulting in 781 patient-years at risk of osteoporosis. Of those, only 83 [10.6%] patient-years were followed by a dual-energy X-ray absorptiometry scan within the same or the following 2 years.Overall, 73 [14.2%] IBD patients (CD: 31 [14.6%], UC: 42 [14%]) and 680 [6.6%, p < 0.001] controls were diagnosed with osteoporosis during follow-up. The risk of osteoporosis was increased compared to the control population (odds ratio: CD: 2.9 [95% confidence interval: 2.0-4.1], UC: 2.8 [2.1-3.9]). CONCLUSION: In this population-based inception cohort, the incidence of osteoporosis was significantly higher compared to a control population. Measurement of bone mineral density is infrequent, especially in patients at high risk of developing osteoporosis. These results demonstrate the need of further awareness of the risk of osteoporosis among IBD patients, and prospective population-based studies are warranted.",
author = "Bobby Lo and Holm, {Jakob Pr{\ae}st} and Vester-Andersen, {Marianne Kajb{\ae}k} and Flemming Bendtsen and Ida Vind and Johan Burisch",
year = "2020",
doi = "10.1093/ecco-jcc/jjaa019",
language = "English",
volume = "14",
pages = "904--914",
journal = "Journal of Crohn's & colitis",
issn = "1873-9946",
publisher = "Oxford University Press",
number = "7",

}

RIS

TY - JOUR

T1 - Incidence, Risk Factors and Evaluation of Osteoporosis in Patients With Inflammatory Bowel Disease

T2 - A Danish Population-Based Inception Cohort With 10 Years of Follow-Up

AU - Lo, Bobby

AU - Holm, Jakob Præst

AU - Vester-Andersen, Marianne Kajbæk

AU - Bendtsen, Flemming

AU - Vind, Ida

AU - Burisch, Johan

PY - 2020

Y1 - 2020

N2 - BACKGROUND: Patients with inflammatory bowel disease [IBD] including Crohn's disease [CD] and ulcerative colitis [UC] are at risk of developing metabolic bone disease. The aims here were to investigate the screening strategy, incidence and risk factors of osteoporosis in a prospective population-based inception cohort. METHOD: Between 2003 and 2004 all incident patients diagnosed with CD and UC in a well-defined Copenhagen area were included and followed until 2015. Data were compared with a control population [at a ratio of 1:20]. Regression models were performed with several covariates. The sensitivity of the Danish registries for osteoporosis was also assessed. RESULTS: A total of 513 patients were included [213 CD, 300 UC]. Overall, 338 (66%, CD: 164 [77%], UC: 174 [58%], p < 0.001] patients received ≥ 500 mg corticosteroid within a year, resulting in 781 patient-years at risk of osteoporosis. Of those, only 83 [10.6%] patient-years were followed by a dual-energy X-ray absorptiometry scan within the same or the following 2 years.Overall, 73 [14.2%] IBD patients (CD: 31 [14.6%], UC: 42 [14%]) and 680 [6.6%, p < 0.001] controls were diagnosed with osteoporosis during follow-up. The risk of osteoporosis was increased compared to the control population (odds ratio: CD: 2.9 [95% confidence interval: 2.0-4.1], UC: 2.8 [2.1-3.9]). CONCLUSION: In this population-based inception cohort, the incidence of osteoporosis was significantly higher compared to a control population. Measurement of bone mineral density is infrequent, especially in patients at high risk of developing osteoporosis. These results demonstrate the need of further awareness of the risk of osteoporosis among IBD patients, and prospective population-based studies are warranted.

AB - BACKGROUND: Patients with inflammatory bowel disease [IBD] including Crohn's disease [CD] and ulcerative colitis [UC] are at risk of developing metabolic bone disease. The aims here were to investigate the screening strategy, incidence and risk factors of osteoporosis in a prospective population-based inception cohort. METHOD: Between 2003 and 2004 all incident patients diagnosed with CD and UC in a well-defined Copenhagen area were included and followed until 2015. Data were compared with a control population [at a ratio of 1:20]. Regression models were performed with several covariates. The sensitivity of the Danish registries for osteoporosis was also assessed. RESULTS: A total of 513 patients were included [213 CD, 300 UC]. Overall, 338 (66%, CD: 164 [77%], UC: 174 [58%], p < 0.001] patients received ≥ 500 mg corticosteroid within a year, resulting in 781 patient-years at risk of osteoporosis. Of those, only 83 [10.6%] patient-years were followed by a dual-energy X-ray absorptiometry scan within the same or the following 2 years.Overall, 73 [14.2%] IBD patients (CD: 31 [14.6%], UC: 42 [14%]) and 680 [6.6%, p < 0.001] controls were diagnosed with osteoporosis during follow-up. The risk of osteoporosis was increased compared to the control population (odds ratio: CD: 2.9 [95% confidence interval: 2.0-4.1], UC: 2.8 [2.1-3.9]). CONCLUSION: In this population-based inception cohort, the incidence of osteoporosis was significantly higher compared to a control population. Measurement of bone mineral density is infrequent, especially in patients at high risk of developing osteoporosis. These results demonstrate the need of further awareness of the risk of osteoporosis among IBD patients, and prospective population-based studies are warranted.

U2 - 10.1093/ecco-jcc/jjaa019

DO - 10.1093/ecco-jcc/jjaa019

M3 - Journal article

C2 - 32016388

AN - SCOPUS:85089125736

VL - 14

SP - 904

EP - 914

JO - Journal of Crohn's & colitis

JF - Journal of Crohn's & colitis

SN - 1873-9946

IS - 7

ER -

ID: 249819506